#METABOLOMICS WORKBENCH xz336_20240729_095642 DATATRACK_ID:5045 STUDY_ID:ST003362 ANALYSIS_ID:AN005508 PROJECT_ID:PR002088
VERSION             	1
CREATED_ON             	August 1, 2024, 5:46 pm
#PROJECT
PR:PROJECT_TITLE                 	Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by
PR:PROJECT_TITLE                 	13C-glutamine after treatment with pimozide
PR:PROJECT_SUMMARY               	Glioblastoma (GBM) cell line U251 was treated with antipsychotic drug pimozide
PR:PROJECT_SUMMARY               	(3 uM) for 24 hr, and then labeled with 13C-glutamine (2 mM) for 1 hr. Cells
PR:PROJECT_SUMMARY               	were collected and extracted for metabolites and analyzed by LC-MS. Our data
PR:PROJECT_SUMMARY               	showed that pimozide treatment significantly increased 13C-labeled glutamine
PR:PROJECT_SUMMARY               	uptake and subsequent consumption, including anaplerosis of metabolites for
PR:PROJECT_SUMMARY               	tricarboxylic acid (TCA) cycle and de novo fatty acid synthesis derived from
PR:PROJECT_SUMMARY               	glutamine-mediated reductive carboxylation process.
PR:INSTITUTE                     	The Ohio State University
PR:DEPARTMENT                    	Radiation Oncology
PR:LAST_NAME                     	Guo
PR:FIRST_NAME                    	Deliang
PR:ADDRESS                       	Department of Radiation Oncology, Ohio State Comprehensive Cancer Center, Arthur
PR:ADDRESS                       	G. James Cancer Hospital and Richard J. Solove Research Institute, and College
PR:ADDRESS                       	of Medicine at The Ohio State University, Columbus, OH 43210, USA.
PR:EMAIL                         	deliang.guo@osumc.edu
PR:PHONE                         	6143663774
#STUDY
ST:STUDY_TITLE                   	Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by
ST:STUDY_TITLE                   	13C-glutamine after treatment with pimozide
ST:STUDY_SUMMARY                 	Glioblastoma (GBM) cell line U251 was treated with antipsychotic drug pimozide
ST:STUDY_SUMMARY                 	(3 uM) for 24 hr, and then labeled with 13C-glutamine (2 mM) for 1 hr. Cells
ST:STUDY_SUMMARY                 	were collected and extracted for metabolites and analyzed by LC-MS. Our data
ST:STUDY_SUMMARY                 	showed that pimozide treatment significantly increased 13C-labeled glutamine
ST:STUDY_SUMMARY                 	uptake and subsequent consumption, including anaplerosis of metabolites for
ST:STUDY_SUMMARY                 	tricarboxylic acid (TCA) cycle and de novo fatty acid synthesis derived from
ST:STUDY_SUMMARY                 	glutamine-mediated reductive carboxylation process.
ST:INSTITUTE                     	The Ohio State University
ST:LAST_NAME                     	Guo
ST:FIRST_NAME                    	Deliang
ST:ADDRESS                       	Department of Radiation Oncology, Ohio State Comprehensive Cancer Center, Arthur
ST:ADDRESS                       	G. James Cancer Hospital and Richard J. Solove Research Institute, and College
ST:ADDRESS                       	of Medicine at The Ohio State University, Columbus, OH 43210, USA.
ST:EMAIL                         	deliang.guo@osumc.edu
ST:PHONE                         	6143663774
#SUBJECT
SU:SUBJECT_TYPE                  	Cultured cells
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	1	LCFA_Control_1	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=LCFA_Control_1.mzML
SUBJECT_SAMPLE_FACTORS           	2	LCFA_Control_2	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=LCFA_Control_2.mzML
SUBJECT_SAMPLE_FACTORS           	3	LCFA_Control_3	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=LCFA_Control_3.mzML
SUBJECT_SAMPLE_FACTORS           	4	LCFA_Control_4	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=LCFA_Control_4.mzML
SUBJECT_SAMPLE_FACTORS           	5	LCFA_Pimozide_1	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=LCFA_Pimozide_1.mzML
SUBJECT_SAMPLE_FACTORS           	6	LCFA_Pimozide_2	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=LCFA_Pimozide_2.mzML
SUBJECT_SAMPLE_FACTORS           	7	LCFA_Pimozide_3	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=LCFA_Pimozide_3.mzML
SUBJECT_SAMPLE_FACTORS           	8	LCFA_Pimozide_4	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=LCFA_Pimozide_4.mzML
SUBJECT_SAMPLE_FACTORS           	9	U251_Control_1_NEG	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=U251_Control_1_NEG.mzML
SUBJECT_SAMPLE_FACTORS           	10	U251_Control_1_POS	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=U251_Control_1_POS.mzML
SUBJECT_SAMPLE_FACTORS           	11	U251_Control_2_NEG	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=U251_Control_2_NEG.mzML
SUBJECT_SAMPLE_FACTORS           	12	U251_Control_2_POS	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=U251_Control_2_POS.mzML
SUBJECT_SAMPLE_FACTORS           	13	U251_Control_3_NEG	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=U251_Control_3_NEG.mzML
SUBJECT_SAMPLE_FACTORS           	14	U251_Control_3_POS	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=U251_Control_3_POS.mzML
SUBJECT_SAMPLE_FACTORS           	15	U251_Control_4_NEG	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=U251_Control_4_NEG.mzML
SUBJECT_SAMPLE_FACTORS           	16	U251_Control_4_POS	Sample source:Human glioblastoma U251 cell line | Treatment:Control	RAW_FILE_NAME=U251_Control_4_POS.mzML
SUBJECT_SAMPLE_FACTORS           	17	U251_Pimozide_1_NEG	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=U251_Pimozide_1_NEG.mzML
SUBJECT_SAMPLE_FACTORS           	18	U251_Pimozide_1_POS	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=U251_Pimozide_1_POS.mzML
SUBJECT_SAMPLE_FACTORS           	19	U251_Pimozide_2_NEG	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=U251_Pimozide_2_NEG.mzML
SUBJECT_SAMPLE_FACTORS           	20	U251_Pimozide_2_POS	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=U251_Pimozide_2_POS.mzML
SUBJECT_SAMPLE_FACTORS           	21	U251_Pimozide_3_NEG	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=U251_Pimozide_3_NEG.mzML
SUBJECT_SAMPLE_FACTORS           	22	U251_Pimozide_3_POS	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=U251_Pimozide_3_POS.mzML
SUBJECT_SAMPLE_FACTORS           	23	U251_Pimozide_4_NEG	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=U251_Pimozide_4_NEG.mzML
SUBJECT_SAMPLE_FACTORS           	24	U251_Pimozide_4_POS	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	RAW_FILE_NAME=U251_Pimozide_4_POS.mzML
SUBJECT_SAMPLE_FACTORS           	25	U251_UNLABELED_NEG	Sample source:Human glioblastoma U251 cell line | Treatment:NA	RAW_FILE_NAME=U251_UNLABELED_NEG.mzML
SUBJECT_SAMPLE_FACTORS           	26	U251_UNLABELED_NEG_2	Sample source:Human glioblastoma U251 cell line | Treatment:NA	RAW_FILE_NAME=U251_UNLABELED_NEG_2.mzML
SUBJECT_SAMPLE_FACTORS           	27	U251_UNLABELED_POS	Sample source:Human glioblastoma U251 cell line | Treatment:NA	RAW_FILE_NAME=U251_UNLABELED_POS.mzML
SUBJECT_SAMPLE_FACTORS           	28	U251_UNLABELED_POS_2	Sample source:Human glioblastoma U251 cell line | Treatment:NA	RAW_FILE_NAME=U251_UNLABELED_POS_2.mzML
#COLLECTION
CO:COLLECTION_SUMMARY            	1) For labelled Group: 3 million U251 cells were seeded in a 15-cm dish for 24
CO:COLLECTION_SUMMARY            	hr, then treated with/without the drug (Pimozide: 3 µM) in a fresh medium
CO:COLLECTION_SUMMARY            	containing 1% FBS, 5 mM glucose, 4 mM glutamine for another 24 hr. After drug
CO:COLLECTION_SUMMARY            	treatment, cells were deprived for 1 hr with a serum-free medium containing 5 mM
CO:COLLECTION_SUMMARY            	glucose, 0 mM glutamine, and 1 mM pyruvate. 2 mM 13C(U)-glutamine was added to
CO:COLLECTION_SUMMARY            	the media and incubated for 1 hr. The cells were washed twice with cold PBS and
CO:COLLECTION_SUMMARY            	quenched with cold acetonitrile and ultrapure water (4:3, v:v) for 5 min, and
CO:COLLECTION_SUMMARY            	metabolites were extracted for subsequent LC-MS analysis. Long chain fatty acid
CO:COLLECTION_SUMMARY            	Control: U251 cells without pimozide treatment. Long chain fatty acid Pimozide:
CO:COLLECTION_SUMMARY            	U251 cells with pimozide treatment.
CO:SAMPLE_TYPE                   	Glioma cells
#TREATMENT
TR:TREATMENT_SUMMARY             	3 million U251 cells were seeded in a 15-cm dish for 24 hr, then treated
TR:TREATMENT_SUMMARY             	with/without Pimozide (3 µM) in a fresh medium containing 1% FBS, 5 mM glucose,
TR:TREATMENT_SUMMARY             	4 mM glutamine for another 24 hr
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	After treatment, the cells were washed twice with cold PBS and quenched with
SP:SAMPLEPREP_SUMMARY            	cold acetonitrile and ultrapure water (4:3, v:v) for 5 min. Metabolites were
SP:SAMPLEPREP_SUMMARY            	then extracted for subsequent LC-MS analysis.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	LC method for long-chain fatty acid detection
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Thermo Dionex Ultimate 3000
CH:COLUMN_NAME                   	Waters ACQUITY UPLC BEH C8 (100 x 2.1mm,1.7um)
CH:SOLVENT_A                     	100% water; 0.1% acetic acid
CH:SOLVENT_B                     	100% acetonitrile; 0.1% acetic acid
CH:FLOW_GRADIENT                 	started with 30% B, hold for 3 min, then increased to 99% B at 20 min, hold for
CH:FLOW_GRADIENT                 	5 min; then hold at 30% B from 25.1 to 28 min
CH:FLOW_RATE                     	0.4 mL/min
CH:COLUMN_TEMPERATURE            	40
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive HF hybrid Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	FullMS data was collected under negative mode. XCMS software was used for
MS:MS_COMMENTS                   	spectrum deconvolution and MetSign software for metabolite identification,
MS:MS_COMMENTS                   	cross-sample peak list alignment, normalization, and statistical analysis.To
MS:MS_COMMENTS                   	identify metabolites, 2DLC-MS/MS data was first matched to our in-house database
MS:MS_COMMENTS                   	that contains parent ion m/z, MS/MS spectra, and retention time of authentic
MS:MS_COMMENTS                   	standards. Threshold for spectral similarity was set ≥ 0.4, while thresholds
MS:MS_COMMENTS                   	of retention time difference and m/z variation window were respectively set ≤
MS:MS_COMMENTS                   	0.15 min and ≤ 5 ppm. 2DLC-MS/MS data without a match with the metabolites in
MS:MS_COMMENTS                   	the in-house database were further analyzed using Compound Discoverer software
MS:MS_COMMENTS                   	(v 2.0, Thermo Fisher Scientific, Germany), where MS/MS spectra similarity score
MS:MS_COMMENTS                   	threshold was set ≥ 40 with a maximum score of 100.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	Counts
MS_METABOLITE_DATA_START
Samples	LCFA_Control_1	LCFA_Control_2	LCFA_Control_3	LCFA_Control_4	LCFA_Pimozide_1	LCFA_Pimozide_2	LCFA_Pimozide_3	LCFA_Pimozide_4
Factors	Sample source:Human glioblastoma U251 cell line | Treatment:Control	Sample source:Human glioblastoma U251 cell line | Treatment:Control	Sample source:Human glioblastoma U251 cell line | Treatment:Control	Sample source:Human glioblastoma U251 cell line | Treatment:Control	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide	Sample source:Human glioblastoma U251 cell line | Treatment:Pimozide
Arachidonic Acid(None)	90866723.74	64480214.13	83430760.95	52284000.99	135939773.5	110365431.1	115455578.7	48793078.59
Arachidonic Acid(13C_8)	87040.4444	54017.60666	63852.38557	56474.70159	71213.07723	94324.82607	44927.37708	26442.94509
Adrenic acid(13C_2)	470238.056	316701.8702	230940.4365	171749.9154	665240.1841	1051065.577	1030946.41	481455.3728
Adrenic acid(None)	76086112	53803141.36	74058217.28	47808858.99	80217254.57	76932457	77118724	34444623.2
alpha-linolenic acid (None)	2099866	814822	955812	560572	1949120.586	3939918.881	1455125	815953
Arachidic acid(13C_2)	11631.34622	18566.36572	10692	2761.847	1116.754947	8576.355644	8433.603488	6192.79852
Arachidic acid(None)	13160879	9292654	10589596	7578618	12866338.37	11905701.82	10642056.49	7814466.47
Behenic acid(None)	4390692.158	3409722.94	3611838.1	2804272.74	9837131.417	9904980.697	9448799.741	7381257.081
Cis-11-eicosenoic acid(13C_2)	718445.6417	440729.1658	498924.1144	600502.8293	464150.1509	387652.809	412066.4445	236264.7131
Cis-11-eicosenoic acid(13C_3)	37837.42872	27781.85828	35404.16179	21368.19366	35664.89042	64812.24762	60285.72653	19880.48678
Cis-11-eicosenoic acid(13C_4)	230974.2313	167930.5911	202601.2336	136730.0929	254833.5099	220121.9447	268711.4581	127245.9508
Cis-11-eicosenoic acid(13C_6)	52162.41681	43515.55615	38862.01446	26992.90753	99026.00434	86195.44902	108759.9238	49351.26524
Cis-11-eicosenoic acid(None)	47759315.51	35165894.8	42770629.19	31805089.9	70737139.27	65272490.07	82187265.5	37295794.93
Dihomo-γ-linolenic acid(13C_8)	253070.1165	114055.9208	189354.3013	94526.24906	197916.168	111427.5971	131145.8842	75433.53968
Dihomo-γ-linolenic acid(None)	13531266.44	10826766.24	15019451.65	10608243.42	21008990.29	19442064.37	20005666.67	6611472.378
Docosahexaenoic acid(None)	50624014.48	33167351.88	45007801.74	29479991.75	58613911.74	52628604.63	51066892.57	23896953.43
Docosapentaenoic acid(None)	25825446.71	17674630.38	24465337.91	15025151.39	24302778.52	22296368.39	22059728.25	9407078.916
Eicosadienoic acid(13C_1)	3721533.898	2929581.664	5208960.627	2930081.599	6063253.372	4309966.07	5197052.975	2534225.179
Eicosadienoic acid(13C_2)	943402.1259	496899.9538	971324.7913	610376.8069	1313604.197	90097.44297	1135256.919	546566.475
Eicosadienoic acid(13C_3)	128411.6629	89277.584	124427.8078	75099.62406	80729.7061	107302.4747	75149.29137	72082.81956
Eicosadienoic acid(13C_4)	82306.71309	69602.08946	104546.7241	64943.74417	149709.1159	118533.8283	143863.8565	53449.87022
Eicosadienoic acid(13C_6)	7145.0276	5773.676625	8623.341057	5377.248957	66869.70856	57332.42705	51089.21875	21199.50564
Eicosadienoic acid(None)	20579785	14724160	20928512.59	13361110.99	27455429.56	24598041.48	23532453.58	11452565.95
Eicosapentaenoic acid(None)	5952366.303	3995592.246	5371962.289	3421626.187	8297307.417	7716033.537	7297168.875	3490297.809
Erucic acid(13C_4)	30984.97533	19286.9375	26822.16611	17101.11604	25979.49197	22110.3408	30860.69217	5655.002854
Erucic acid(None)	8721740.727	6330763.469	8804134.37	6467593.831	15724777.5	15613095.76	18065670.48	9888139.262
Heneicosylic acid(None)	3207591.205	1867572.79	2540722.383	1555809.201	2803251.526	2637267.573	2490712.418	2020986.533
Linoleic Acid (13C_2)	358754.2386	124748.4562	265051.8649	212210.3387	1115425.072	1060184.386	2065033.688	511378.0012
Linoleic Acid (13C_4)	152481.4926	87251.93755	113591.3881	79629.30749	241438.746	525664.4831	465106.1224	261084.49
Linoleic Acid (13C_6)	0	0	0	0	287772.9912	237940.0526	246500.5372	102513.9492
Linoleic Acid (13C_8)	0	0	0	0	94122.3278	75943.17804	74730.24313	25895.03199
Linoleic Acid (None)	40035577	22902173.05	31935814.04	19652388.35	28448776.18	63422464.9	40467492.46	18152622.4
Lauric acid(13C_2)	0	0	0	0	217699.5385	194125.1313	199185.571	92521.88683
Lauric acid(None)	84712770.88	63644477.67	71486725.17	52827418.23	70508238.53	68672062.57	61654076.85	33322282.33
Linoelaidic acid(13C_1)	2751470.496	2905991.832	4167753.594	2522520.489	5942657.689	15902503.82	4965190.027	2406015.211
Linoelaidic acid(None)	13981515	14710919.78	21254555.25	12818112.39	30256489.9	80505284.33	25195031.99	12153027.48
Margaric acid(None)	43802859.35	20046863.65	28508767.5	17072671.45	33629876.29	31066306	23262331.46	24290572.08
Myristic acid(None)	284204734.3	113379476.5	147013581.3	85731123.25	146220829	177555992.5	120176630.1	59952423.62
Myristic acid(13C_1)	1272485.495	519795.0811	212712.1076	391877.1374	378919.6571	977782.2714	270762.9167	154696.2658
Myristic acid(13C_2)	1996042.452	1420169.729	2074739.713	1138009.053	5050712.782	4374040.663	4348610.197	2035484.743
Myristic acid(13C_4)	677657.4345	509396.7624	646163.4937	438469.3495	2696784.005	2518919.719	2365467.746	1136621.031
Myristic acid(13C_6)	86275.58179	82170.85556	94776.93808	78516.50738	1002330.701	872158.0539	851632.8054	409697.9624
Nervonic acid(13C_2)	97112.4855	105260.085	118545.254	84502.60904	59619.20814	47006.45026	70765.37874	38426.56222
Nervonic acid(13C_4)	14677.50019	11002.73084	17736.96035	6346.990725	1762.684609	1760.273041	1873.853563	1293.672952
Nervonic acid(None)	6790214.189	6082021.821	6902219.26	5342643.952	26383010.32	26359446.33	28037673.47	19368400.07
Nonadecylic acid(None)	4042619.479	3310819.921	2628089.606	1669318.24	3846094.263	3513959.863	2610713.679	1836770.232
Oleic acid(13C_2)	4076058.709	6408451.189	500387.5827	5044822.085	849698.8473	5859058.013	6251161.988	3683430.567
Oleic acid(13C_3)	497452.8178	137450.1402	1091568.891	107069.1304	782644.3188	109485.0237	81341.43547	54523.21753
Oleic acid(13C_4)	3535195.583	2538441.169	3076516.714	2112010.806	4392709.679	3966294.041	2781505.885	2000723.097
Oleic acid(13C_6)	977367.7125	791383.9357	795232.0053	674517.7825	1383201.829	1856497.938	1768843.672	927173.4039
Oleic acid(None)	536340869.8	504075596.6	501800469.3	425782502.7	736549323.1	572350109.4	539012782.9	340744780.7
Palmitelaidic acid(None)	80816352.21	44145970.08	47005471.76	29402402.76	54624990.08	482719956.9	41937875.79	20053136.16
Palmitelaidic acid(13C_4)	539977.275	400037.8862	443738.7963	313676.178	819310.3974	777148.6144	761792.2768	349682.5341
Palmitelaidic acid(13C_6)	177444.7227	85452.88055	108670.7995	64954.83898	345053.8914	2990401.298	293229.6096	126190.2394
Palmitic acid(13C_2)	3376364.267	3403646.285	2268063.324	2932192.198	2509056.393	2450403.904	3185932.883	1238500.677
Palmitic acid(13C_4)	1923257.124	1851651.174	2183343.871	1617317.864	2454197.047	2185522.464	2405337.626	1338723.573
Palmitic acid(13C_6)	133559.507	252623.221	285968	229646	1002186.168	815307.7571	849302.4058	510728.0598
Palmitic acid(None)	1084810268	812269008.6	1115062720	757364334.4	851413497	830287278	800706481.5	567371010.5
palmitoleic acid(None)	54890201.41	41276904.43	71320376.81	31691572.07	110344649.5	112448913	96479497.93	48362383.77
palmitoleic acid(13C_2)	0	0	0	0	1680028.422	1701448.642	400573.7526	774594.6877
palmitoleic acid(13C_3)	163057.8724	97535.51771	209846.737	69905.38217	215879.0546	218631.4943	264321.564	72060.61202
palmitoleic acid(13C_4)	685402.681	511810.5955	682698.9896	442757.4087	3331557.642	3017647.401	2892764.525	1408780.284
palmitoleic acid(13C_6)	142460.7915	99853.98693	150354.9418	92044.7865	1448304.69	1245791.855	1241717.414	619147.6328
palmitoleic acid(13C_8)	0	0	0	0	485204.7512	397915.5611	385833.2916	179480.4216
palmitoleic acid(13C_10)	0	0	0	0	43872.09649	42795.03202	40033.48582	20238.77725
Pentadecylic acid(None)	121639763.4	25285294.79	32561855.28	19113856.74	35802697.61	99821391.92	24916122.69	13062774.7
Pinolenic acid(None)	11572422.06	6024750.384	7668754.699	4969872.283	22084126.55	20336870.19	17671487.81	8743221.783
Pinolenic acid(13C_2)	194192	230433.5501	283744.4	186569.6514	857862.8418	961161.9832	678568.6451	301546.7458
Pinolenic acid(13C_3)	0	0	0	0	60851.09446	45407.68834	40189.39573	16220.56248
Pinolenic acid(13C_4)	75773.17692	51314.87119	86426.14831	40444.54567	627055.9634	508604.1518	487747.3686	253003.6602
Pinolenic acid(13C_6)	0	0	0	0	159929.6515	88510.68704	110539.7245	32502.28247
Stearic acid(13C_4)	372632.0819	387400.5071	392495.2414	332221.2155	253770.9643	292957.7714	294172.4076	176840.4574
Stearic acid(None)	558177009.5	522860528.5	577054006.3	480877162.6	542022482	522163522.3	482973361	364920051.2
stearidonic acid(None)	294797.3966	202013.4521	464877.0466	185233.2657	1016200.755	1049677.078	837752.0172	386562.3979
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	M/Z	RT_min	InHouse_CAS
Arachidonic Acid(None)	303.2331072	14.19	Standard database
Arachidonic Acid(13C_8)	311.2589876	14.19	Standard database
Adrenic acid(13C_2)	333.2706949	15.29	Standard database
Adrenic acid(None)	331.2646809	15.29	Standard database
alpha-linolenic acid (None)	277.2175185	13.3	Standard database
Arachidic acid(13C_2)	313.3021641	17.42	Standard database
Arachidic acid(None)	311.2958456	17.42	Standard database
Behenic acid(None)	339.3275867	18.49	Standard database
Cis-11-eicosenoic acid(13C_2)	311.2860359	16.47	Standard database
Cis-11-eicosenoic acid(13C_3)	312.2897525	16.47	Standard database
Cis-11-eicosenoic acid(13C_4)	313.2928683	16.47	Standard database
Cis-11-eicosenoic acid(13C_6)	315.300047	16.47	Standard database
Cis-11-eicosenoic acid(None)	309.2800312	16.47	Standard database
Dihomo-γ-linolenic acid(13C_8)	313.2750066	14.76	Standard database
Dihomo-γ-linolenic acid(None)	305.2483414	14.76	Standard database
Docosahexaenoic acid(None)	327.2331147	14.07	Standard database
Docosapentaenoic acid(None)	329.2489022	14.55	Standard database
Eicosadienoic acid(13C_1)	308.2676544	15.57	Standard database
Eicosadienoic acid(13C_2)	309.2708244	15.57	Standard database
Eicosadienoic acid(13C_3)	310.2737099	15.57	Standard database
Eicosadienoic acid(13C_4)	311.2778613	15.57	Standard database
Eicosadienoic acid(13C_6)	313.2848347	15.57	Standard database
Eicosadienoic acid(None)	307.2646321	15.57	Standard database
Eicosapentaenoic acid(None)	301.2176184	13.34	Standard database
Erucic acid(13C_4)	341.3249465	17.61	Standard database
Erucic acid(None)	337.3114342	17.61	Standard database
Heneicosylic acid(None)	325.3115874	17.98	Standard database
Linoleic Acid (13C_2)	281.2388832	14.21	Standard database
Linoleic Acid (13C_4)	283.2462158	14.21	Standard database
Linoleic Acid (13C_6)	0	14.21	Standard database
Linoleic Acid (13C_8)	0	14.21	Standard database
Linoleic Acid (None)	279.2330331	14.21	Standard database
Lauric acid(13C_2)	0	11.33	Standard database
Lauric acid(None)	199.1707696	11.33	Standard database
Linoelaidic acid(13C_1)	280.2365217	14.58	Standard database
Linoelaidic acid(None)	279.233185	14.58	Standard database
Margaric acid(None)	269.2486257	15.49	Standard database
Myristic acid(None)	227.202112	13.16	Standard database
Myristic acid(13C_1)	228.204705	13.16	Standard database
Myristic acid(13C_2)	229.2078844	13.16	Standard database
Myristic acid(13C_4)	231.2152992	13.16	Standard database
Myristic acid(13C_6)	233.2223306	13.16	Standard database
Nervonic acid(13C_2)	367.3492931	18.61	Standard database
Nervonic acid(13C_4)	369.3564795	18.61	Standard database
Nervonic acid(None)	365.3430189	18.61	Standard database
Nonadecylic acid(None)	297.2802124	16.82	Standard database
Oleic acid(13C_2)	283.2541582	15.19	Standard database
Oleic acid(13C_3)	284.2580084	15.19	Standard database
Oleic acid(13C_4)	285.2616629	15.19	Standard database
Oleic acid(13C_6)	287.2689265	15.19	Standard database
Oleic acid(None)	281.2488997	15.19	Standard database
Palmitelaidic acid(None)	253.2174629	13.86	Standard database
Palmitelaidic acid(13C_4)	257.2301705	13.86	Standard database
Palmitelaidic acid(13C_6)	259.2373903	13.86	Standard database
Palmitic acid(13C_2)	257.2385838	14.77	Standard database
Palmitic acid(13C_4)	259.2457344	14.77	Standard database
Palmitic acid(13C_6)	261.2521058	14.77	Standard database
Palmitic acid(None)	255.233184	14.77	Standard database
palmitoleic acid(None)	253.217497	13.68	Standard database
palmitoleic acid(13C_2)	0	13.68	Standard database
palmitoleic acid(13C_3)	256.2267393	13.68	Standard database
palmitoleic acid(13C_4)	257.2305894	13.68	Standard database
palmitoleic acid(13C_6)	259.2375427	13.68	Standard database
palmitoleic acid(13C_8)	0	13.68	Standard database
palmitoleic acid(13C_10)	0	13.68	Standard database
Pentadecylic acid(None)	241.2175152	13.98	Standard database
Pinolenic acid(None)	277.217519	13.63	Standard database
Pinolenic acid(13C_2)	279.223816	13.63	Standard database
Pinolenic acid(13C_3)	0	13.63	Standard database
Pinolenic acid(13C_4)	281.2308866	13.63	Standard database
Pinolenic acid(13C_6)	0	13.63	Standard database
Stearic acid(13C_4)	287.2774938	16.19	Standard database
Stearic acid(None)	283.2645021	16.19	Standard database
stearidonic acid(None)	275.2016354	12.58	Standard database
METABOLITES_END
#END